REGN Competitors & Alternatives
Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
REGN
Main Stock$819.09
Tradestie Score
44
Market Cap
$63.59B
P/E Ratio
19.9
Revenue Growth
0.2%
Analyst Upside
+5.7%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GILD
Gilead Sciences Inc
|
$157.19
|
$137.92B | - | 43 | Compare |
|
VRTX
Vertex Pharmaceuticals Inc
|
$535.17
|
$103.64B | 30.4 | 49 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$227.28
|
$60.38B | 38.0 | 50 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$875.76
|
$46.96B | 33.9 | 52 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$382.27
|
$36.81B | 68.8 | 39 | Compare |
|
INSM
Insmed, Inc.
|
$95.06
|
$31.13B | - | 52 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$89.67
|
$24.57B | - | 63 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$253.84
|
$22.61B | 42.8 | 39 | Compare |
|
GMAB
Genmab A/S ADS
|
$40.00
|
$19.56B | 31.2 | 37 | Compare |
|
INCY
Incyte Genomics Inc
|
$116.93
|
$16.93B | 14.5 | 77 | Compare |
More REGN Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
221 stocks in this industry